BISHOPS STORTFORD, England, December 11, 2013 /PRNewswire/ --
Dotmatics' Vortex to be used to uncover new drug lead compounds for Alzheimer's disease
Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, announced today that the research foundation AlzeCure, has deployed and integrated the data visualization and analysis tool Vortex. AlzeCure is a novel innovative drug discovery unit that will use Vortex to help in the quest to discover and develop novel therapies for the treatment of Alzheimer's disease and other neurodegenerative disorders.
Dotmatics' Vortex is a dynamic analytic and visualization tool designed specifically for the analysis and interrogation of scientific data including chemical structures, biological assays, text, numbers, images and chemical properties. Vortex provides users with an out-of the-box filtering, charting, plotting and chemically aware calculation engine, thus enabling scientists to evaluate large datasets in a rich, intuitive and flexible user interface. The use of Vortex helps to uncover hidden data trends and correlations, consequently identifying new potential drug candidates.
After extensive testing, AlzeCure selected Dotmatics' Vortex because of its "extensive visualization functionality and analysis algorithms, ease of use, and ability to run on Mac OS X as well as Windows," says Dr. Gunnar Nordvall, Head of Medicinal and Computational Chemistry at AlzeCure. "We can rapidly evaluate results from us and our partners and it enables us to make quick decisions about our candidate compounds."
"Research at AlzeCure aims to tackle a devastating disease. We are pleased to have been chosen as the informatics platform to help accelerate the discovery of new drugs to treat Alzheimer's disease," said Dr. Mike Hartshorn, CSO of Dotmatics. "We continue our path of strong investment in Vortex to make sure that it continues to be the best data analysis and visualization tool for scientists."
At the forefront of innovation, Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile pharmaceutical, biotechnology and chemical industries as well as academia. Dotmatics' enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organizations, from discovery research to development and early manufacturing. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualization. Dotmatics solutions are available for local or cloud deployment and they are supported on Microsoft Windows, Mac OS X and Linux. A privately owned company, Dotmatics was founded in 2005 and their headquarters is based south of Cambridge in the UK.
Tel (Europe): +44(0)1279-654-123
Tel (US West Coast): +1(619)419-2808
Tel (US East Coast): +1(781)281-2330